Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Rafarma Pharmaceuticals Inc. Stories

2014-04-10 08:30:56

MOSCOW, April 10, 2014 /PRNewswire/ -- In response to shareholder inquiries, CEO Dave Anderson offers further comment on the improved financial position of Rafarma: "Due to the overwhelming response to our recent news release regarding the VEBank loan restructuring the company would like to provide some additional details," said Anderson. A key element of the restructuring is a deferment creating significant cost savings--particularly when compounded. Another very significant element...

2014-02-05 08:29:25

MOSCOW, Feb. 5, 2014 /PRNewswire/ -- On February 3, 2014, ZAO Rafarma management met with senior faculty members of the St. Petersburg Academy of Pharmaceutical Chemistry to create a long-term cooperative agreement. Rafarma will work with and be able to recruit from the finest pharmaceutical specialists graduating in Russia, as well as having access to the Academy's innovative pharmaceutical research. The cooperative agreement is borne out of the initiatives outlined in "Pharma...

2014-01-28 12:29:35

MOSCOW, Jan. 28, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA) and St. Petersburg-based Pharmsynthez have opened discussions for Joint Venture Production. At meetings initiated by Governor Oleg Korolev of Lipetsk, Management from Rafarma and Pharmsynthez have agreed in principal to commence a 'joint venture production plan', with the potential to substantially increase revenues for both companies. The agreement is contingent upon a satisfactory technical audit of...

2013-12-12 16:25:40

MOSCOW, Dec. 12, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA), announces a $1.2 million private placement. A $1.2 million private placement has been closed with a share price of $0.65 per share. Proceeds from this private placement are being applied to company expansion and to reduce commercial debt. Stated CEO Dave Anderson: "As Rafarma continues to develop new manufacturing partners, we anticipate that this private placement is just the beginning of a vibrant...

2013-11-11 12:26:05

MOSCOW, Nov. 11, 2013 /PRNewswire/ -- Executive leadership at Rafarma Pharmaceuticals (OTC:RAFA), recently met with the Governor of Lipetsk, Oleg Korolev, along with several government economic development representatives, including the Trade mission of the Russian Federation in Great Britain and announced plans for British investment in the region to create a "biopharmaceutical cluster" in Terbuny. The parties signed a project initiative to increase growth of the pharmaceutical...

2013-10-02 12:29:00

MOSCOW, Oct. 2, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA), which previously announced plans for a full audit and a streamlining of its corporate structure, plans to prepare and publish consolidated financial reports in anticipation of the audit. As part of Rafarma's ongoing effort to streamline and consolidate its corporate structure, revised financial reports are being prepared which consolidate the revenue reporting of Rafarma and its subsidiary production plant....

2013-09-19 08:29:49

MOSCOW, Sept. 19, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA), in an effort to upgrade its market listing has announced plans for a full audit and a streamlining of its corporate structure. With recent advancements in production contract business development, as well as interest from several strategic partners, Rafarma will engage the services of a PCAOB registered audit firm. The Company also plans to streamline its corporate structure which will greatly lower...

2013-09-10 08:32:07

TERBUNY, Russia, Sept. 10, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc., OTC symbol "RAFA," announced it has entered into a new multi-year distribution contract with Amber Pharma Distribution Group, a boutique international business development firm. The principals of Amber Pharma have more than 75 years of combined international business development experience in a wide range of industry sectors including pharmaceuticals, finance, software, telecommunications and trade. It is...

2013-02-04 08:26:48

SANDY, Utah, Feb. 4, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc. (the "Company") OTC symbol (RAFA) announced that it has received the general license for pharmaceutical products and has started the manufacturing of 3 new products. The general license was one of the final steps required to open the new plant in Terbuniy. The Company is now in operation and is expected to rapidly increase to 100% capacity of the Terbiniy facility with the addition of government contracts provided by...

2013-01-31 08:31:01

SANDY, Utah, Jan. 31, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc. (the "Company") OTC symbol "RAFA" announced that it has been named one of the four national strategic Pharmaceutical Suppliers to the Russian Federation. This important step for the company means it will receive guaranteed government contracts helping load the manufacturing facility to 100% capacity. The Russian pharmaceutical industry supplies both the national health care system and hospital sector with 70% of...